Company Overview
HUMACYTE, INC.
HUMARevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
2M
2025 FY
Net Income
-41M
2025 FY
Shares Outstanding
158M
2025 FY
EPS
-0.26USD
2025 FY
Company Information
SIC Code
2836
CIK Code
1818382
Exchange
Nasdaq
Location
US